{"id":257,"date":"2021-10-19T15:17:13","date_gmt":"2021-10-19T17:17:13","guid":{"rendered":"https:\/\/sites.usp.br\/limca\/?page_id=257"},"modified":"2023-05-19T18:19:52","modified_gmt":"2023-05-19T20:19:52","slug":"publicacoes","status":"publish","type":"page","link":"https:\/\/sites.usp.br\/limca\/publicacoes\/","title":{"rendered":"Publica\u00e7\u00f5es"},"content":{"rendered":"

– Arfelli, V.C.; Chang, Y.C.; Bagnoli, J.W.; Kerb, P.; Ciamponi, F.E.; Paz, L.M.D.S.; Pankivskyi, S.; de Matha Salone, J.; Maucuer, A.; Massirer, K.B.; Enard, W.; Kuster, B.; Greif, P.A.; Archangelo, L.F. (2023). UHMK1 is a novel splicing regulatory kinase. Journal of Biological Chemistry. https:\/\/doi.org\/10.1016\/j.jbc.2023.103041<\/a><\/p>\n

– Serafim, R.B.; Cardoso, C.; Arfelli, V.C.; Valente, V.; Archangelo, L.F. (2022). PIMREG expression level predicts glioblastoma patient survival and affects temozolomide resistance and DNA damage response. Biochim. Biophys. Acta Mol. Basis Dis. https:\/\/doi.org\/10.1016\/j.bbadis.2022.166382<\/a><\/p>\n

– Arfelli, V.C. and Archangelo, L.F. (2022). Book chapter. Alternative Splicing of Pre-messenger RNA. Transcriptomics in Health and Disease (2nd<\/sup> Edition). Ed. Springer Nature. https:\/\/doi.org\/10.1007\/978-3-030-87821-4_2<\/a><\/p>\n

– Campos, L.W., Zenatti, P.P., Pissinato, L.G, Rodrigues, G.O.L, Artico, L.L, Guimar\u00e3es, T.R, Archangelo, L. F., Mart\u00ednez, L, Brooks, A.J., Yunes, J.A. (2019). Oncogenic basic amino acid insertions at the extracellular juxtamembrane region of IL7R\u03b1 cause receptor hypersensitivity. BLOOD. <\/span>https:\/\/doi.org\/10.1182\/blood-2018-09-872945<\/a><\/p>\n

– Barbutti, I., Machado-Neto, J., Arfelli, V., Campos, P., Traina, F., Saad, S.T.O, Archangelo, L.F. (2018). The U2AF homology motif kinase 1 (UHMK1) is upregulated upon hematopoietic cell differentiation. Biochim Biophys Acta. https:\/\/doi.org\/10.1016\/j.bbadis.2018.01.004<\/a><\/p>\n

– Arfelli, V.C.; Archangelo, L.F. (2018). UHMK1 (U2AF homology motif kinase 1); Atlas Genet Cytogenet Oncol Haematol. https:\/\/doi.org\/10.4267\/2042\/68931<\/a><\/p>\n

– Archangelo, L.F. (2017). PIMREG (PICALM interacting mitotic regulator); Atlas Genet Cytogenet Oncol Haematol. https:\/\/doi.org\/10.4267\/2042\/68737<\/a><\/p>\n

– Barbutti, I., Xavier-Ferrucio, J.M., Machado-Neto, J.A., Ricon, L., Traina, F., Bohlander, S.K., Saad, S.T.O. and Archangelo L.F. (2016). CATS (FAM64A) abnormal expression reduces clonogenicity of hematopoietic cells. Oncotarget. https:\/\/doi.org\/10.18632\/oncotarget.11724<\/a><\/p>\n

– Archangelo, L.F., Greif, P.A., Maucuer, A., Manceau, V., Koneru, N., Bigarella, C.L., Niemann, F., dos Santos, M.T., Kobarg, J., Bohlander, S.K., Saad S. T. O. (2013). The CATS (FAM64A) protein is a substrate of the Kinase Interacting Stathmin (KIS). Biochimica et biophysica acta. https:\/\/doi.org\/10.1016\/j.bbamcr.2013.02.004<\/a><\/p>\n

– Archangelo, L. F., Greif, P., Holzel, M., Harasim,\u00a0 T.,\u00a0 Kremmer,\u00a0\u00a0 E., Przemeck, G., Eick, D., Deshpande, A., Buske, C, Deangelis, M. H., Saad S. T. O., Bohlander S. K. (2008). The CALM and CALM\/AF10 interactor CATS is a marker for proliferation. Molecular Oncology. https:\/\/doi.org\/10.1016\/j.molonc.2008.08.001<\/a><\/p>\n

– Archangelo, L.F., Glasner, J., Krause, A. and Bohlander, S.K. (2006). The novel CALM interactor CATS influences the subcellular localization of the leukemogenic fusion protein CALM\/AF10. Oncogene. https:\/\/doi.org\/10.1038\/sj.onc.1209438<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

– Arfelli, V.C.; Chang, Y.C.; Bagnoli, J.W.; Kerb, P.; Ciamponi, F.E.; Paz, L.M.D.S.; Pankivskyi, S.; de Matha Salone, J.; Maucuer, A.; Massirer, K.B.; Enard, W.; Kuster, B.; Greif, P.A.; Archangelo, L.F. (2023). UHMK1 is a novel splicing regulatory kinase. Journal of Biological Chemistry. https:\/\/doi.org\/10.1016\/j.jbc.2023.103041 – Serafim, R.B.; Cardoso, C.; Arfelli, V.C.; Valente, V.; Archangelo, L.F. […]<\/p>\n","protected":false},"author":635,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"ocean_post_layout":"","ocean_both_sidebars_style":"","ocean_both_sidebars_content_width":0,"ocean_both_sidebars_sidebars_width":0,"ocean_sidebar":"0","ocean_second_sidebar":"0","ocean_disable_margins":"enable","ocean_add_body_class":"","ocean_shortcode_before_top_bar":"","ocean_shortcode_after_top_bar":"","ocean_shortcode_before_header":"","ocean_shortcode_after_header":"","ocean_has_shortcode":"","ocean_shortcode_after_title":"","ocean_shortcode_before_footer_widgets":"","ocean_shortcode_after_footer_widgets":"","ocean_shortcode_before_footer_bottom":"","ocean_shortcode_after_footer_bottom":"","ocean_display_top_bar":"default","ocean_display_header":"default","ocean_header_style":"","ocean_center_header_left_menu":"0","ocean_custom_header_template":"0","ocean_custom_logo":0,"ocean_custom_retina_logo":0,"ocean_custom_logo_max_width":0,"ocean_custom_logo_tablet_max_width":0,"ocean_custom_logo_mobile_max_width":0,"ocean_custom_logo_max_height":0,"ocean_custom_logo_tablet_max_height":0,"ocean_custom_logo_mobile_max_height":0,"ocean_header_custom_menu":"0","ocean_menu_typo_font_family":"0","ocean_menu_typo_font_subset":"","ocean_menu_typo_font_size":0,"ocean_menu_typo_font_size_tablet":0,"ocean_menu_typo_font_size_mobile":0,"ocean_menu_typo_font_size_unit":"px","ocean_menu_typo_font_weight":"","ocean_menu_typo_font_weight_tablet":"","ocean_menu_typo_font_weight_mobile":"","ocean_menu_typo_transform":"","ocean_menu_typo_transform_tablet":"","ocean_menu_typo_transform_mobile":"","ocean_menu_typo_line_height":0,"ocean_menu_typo_line_height_tablet":0,"ocean_menu_typo_line_height_mobile":0,"ocean_menu_typo_line_height_unit":"","ocean_menu_typo_spacing":0,"ocean_menu_typo_spacing_tablet":0,"ocean_menu_typo_spacing_mobile":0,"ocean_menu_typo_spacing_unit":"","ocean_menu_link_color":"","ocean_menu_link_color_hover":"","ocean_menu_link_color_active":"","ocean_menu_link_background":"","ocean_menu_link_hover_background":"","ocean_menu_link_active_background":"","ocean_menu_social_links_bg":"","ocean_menu_social_hover_links_bg":"","ocean_menu_social_links_color":"","ocean_menu_social_hover_links_color":"","ocean_disable_title":"default","ocean_disable_heading":"default","ocean_post_title":"","ocean_post_subheading":"","ocean_post_title_style":"","ocean_post_title_background_color":"","ocean_post_title_background":0,"ocean_post_title_bg_image_position":"","ocean_post_title_bg_image_attachment":"","ocean_post_title_bg_image_repeat":"","ocean_post_title_bg_image_size":"","ocean_post_title_height":0,"ocean_post_title_bg_overlay":0.5,"ocean_post_title_bg_overlay_color":"","ocean_disable_breadcrumbs":"default","ocean_breadcrumbs_color":"","ocean_breadcrumbs_separator_color":"","ocean_breadcrumbs_links_color":"","ocean_breadcrumbs_links_hover_color":"","ocean_display_footer_widgets":"default","ocean_display_footer_bottom":"default","ocean_custom_footer_template":"0","footnotes":"","_links_to":"","_links_to_target":""},"class_list":["post-257","page","type-page","status-publish","hentry","entry"],"_links":{"self":[{"href":"https:\/\/sites.usp.br\/limca\/wp-json\/wp\/v2\/pages\/257","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sites.usp.br\/limca\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/sites.usp.br\/limca\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/sites.usp.br\/limca\/wp-json\/wp\/v2\/users\/635"}],"replies":[{"embeddable":true,"href":"https:\/\/sites.usp.br\/limca\/wp-json\/wp\/v2\/comments?post=257"}],"version-history":[{"count":5,"href":"https:\/\/sites.usp.br\/limca\/wp-json\/wp\/v2\/pages\/257\/revisions"}],"predecessor-version":[{"id":468,"href":"https:\/\/sites.usp.br\/limca\/wp-json\/wp\/v2\/pages\/257\/revisions\/468"}],"wp:attachment":[{"href":"https:\/\/sites.usp.br\/limca\/wp-json\/wp\/v2\/media?parent=257"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}